Meta-hlorofenilpiperazin (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Meta-hlorofenilpiperazin" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

17nih.gov

4^th place

3^rd place

15doi.org

2^nd place

5elsevier.com

610^th place

525^th place

3wikipedia.org

low place

2archive.today

14^th place

30^th place

2wiley.com

222^nd place

57^th place

2archive.org

6^th place

5^th place

1sciencedirect.com

149^th place

32^nd place

1jcheminf.com

low place

33^rd place

1sagepub.com

731^st place

1,123^rd place

1ama-assn.org

3,257^th place

1,213^th place

ama-assn.org

archpsyc.ama-assn.org

Hollander E, DeCaria CM, Nitescu A, et al. (January 1992). „Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers”. Archives of General Psychiatry 49 (1): 21–8. PMID 1728249. ^{[mrtav link]}

archive.org

Klein E, Zohar J, Geraci MF, Murphy DL, Uhde TW (November 1991). „Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects”. Biological Psychiatry 30 (10): 973–84. DOI:10.1016/0006-3223(91)90119-7. PMID 1756202.
Charney DS, Woods SW, Goodman WK, Heninger GR (1987). „Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects”. Psychopharmacology 92 (1): 14–24. PMID 3110824.

archive.today

Bossong MG, Van Dijk JP, Niesink RJ (December 2005). „Methylone and mCPP, two new drugs of abuse?”. Addiction Biology 10 (4): 321–3. DOI:10.1080/13556210500350794. PMID 16318952. Arhivirano iz originala na datum 2013-01-05. Pristupljeno 2014-04-05.
Vogels N, Brunt TM, Rigter S, van Dijk P, Vervaeke H, Niesink RJ (December 2009). „Content of ecstasy in the Netherlands: 1993-2008”. Addiction (Abingdon, England) 104 (12): 2057–66. DOI:10.1111/j.1360-0443.2009.02707.x. PMID 19804461. Arhivirano iz originala na datum 2013-01-05. Pristupljeno 2014-04-05.

doi.org

dx.doi.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
Bossong MG, Van Dijk JP, Niesink RJ (December 2005). „Methylone and mCPP, two new drugs of abuse?”. Addiction Biology 10 (4): 321–3. DOI:10.1080/13556210500350794. PMID 16318952. Arhivirano iz originala na datum 2013-01-05. Pristupljeno 2014-04-05.
Bossong M, Brunt T, Van Dijk J, et al. (March 2009). „mCPP: an undesired addition to the ecstasy market”. Journal of Psychopharmacology (Oxford, England) 24 (9): 1395–401. DOI:10.1177/0269881109102541. PMID 19304863. ^{[mrtav link]}
Vogels N, Brunt TM, Rigter S, van Dijk P, Vervaeke H, Niesink RJ (December 2009). „Content of ecstasy in the Netherlands: 1993-2008”. Addiction (Abingdon, England) 104 (12): 2057–66. DOI:10.1111/j.1360-0443.2009.02707.x. PMID 19804461. Arhivirano iz originala na datum 2013-01-05. Pristupljeno 2014-04-05.
Tancer M, Johanson CE (October 2003). „Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP”. Drug and Alcohol Dependence 72 (1): 33–44. DOI:10.1016/S0376-8716(03)00172-8. PMID 14563541.
Rajkumar R, Pandey DK, Mahesh R, Radha R (April 2009). „1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay”. European Journal of Pharmacology 608 (1-3): 32–41. DOI:10.1016/j.ejphar.2009.02.041. PMID 19269287.
Kennett GA, Whitton P, Shah K, Curzon G (May 1989). „Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists”. European Journal of Pharmacology 164 (3): 445–54. DOI:10.1016/0014-2999(89)90252-5. PMID 2767117.
Klein E, Zohar J, Geraci MF, Murphy DL, Uhde TW (November 1991). „Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects”. Biological Psychiatry 30 (10): 973–84. DOI:10.1016/0006-3223(91)90119-7. PMID 1756202.
Van Veen JF, Van der Wee NJ, Fiselier J, Van Vliet IM, Westenberg HG (October 2007). „Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine (m-CPP) in patients with generalized social anxiety disorder, panic disorder and healthy controls”. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology 17 (10): 637–42. DOI:10.1016/j.euroneuro.2007.03.005. PMID 17481859.
van der Wee NJ, Fiselier J, van Megen HJ, Westenberg HG (October 2004). „Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine in patients with panic disorder and controls”. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology 14 (5): 413–7. DOI:10.1016/j.euroneuro.2004.01.001. PMID 15336303.
Broocks A, Pigott TA, Hill JL, et al. (June 1998). „Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results”. Psychiatry Research 79 (1): 11–20. DOI:10.1016/S0165-1781(98)00029-8. PMID 9676822.
Pigott TA, Zohar J, Hill JL, et al. (March 1991). „Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder”. Biological Psychiatry 29 (5): 418–26. DOI:10.1016/0006-3223(91)90264-M. PMID 2018816.

elsevier.com

linkinghub.elsevier.com

Tancer M, Johanson CE (October 2003). „Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP”. Drug and Alcohol Dependence 72 (1): 33–44. DOI:10.1016/S0376-8716(03)00172-8. PMID 14563541.
Rajkumar R, Pandey DK, Mahesh R, Radha R (April 2009). „1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay”. European Journal of Pharmacology 608 (1-3): 32–41. DOI:10.1016/j.ejphar.2009.02.041. PMID 19269287.
Van Veen JF, Van der Wee NJ, Fiselier J, Van Vliet IM, Westenberg HG (October 2007). „Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine (m-CPP) in patients with generalized social anxiety disorder, panic disorder and healthy controls”. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology 17 (10): 637–42. DOI:10.1016/j.euroneuro.2007.03.005. PMID 17481859.
van der Wee NJ, Fiselier J, van Megen HJ, Westenberg HG (October 2004). „Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine in patients with panic disorder and controls”. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology 14 (5): 413–7. DOI:10.1016/j.euroneuro.2004.01.001. PMID 15336303.
Broocks A, Pigott TA, Hill JL, et al. (June 1998). „Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results”. Psychiatry Research 79 (1): 11–20. DOI:10.1016/S0165-1781(98)00029-8. PMID 9676822.

jcheminf.com

Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

nih.gov

ncbi.nlm.nih.gov

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
Bossong MG, Van Dijk JP, Niesink RJ (December 2005). „Methylone and mCPP, two new drugs of abuse?”. Addiction Biology 10 (4): 321–3. DOI:10.1080/13556210500350794. PMID 16318952. Arhivirano iz originala na datum 2013-01-05. Pristupljeno 2014-04-05.
Lecompte Y, Evrard I, Arditti J (2006). „[Metachlorophenylpiperazine (mCPP): a new designer drug]” (French). Thérapie 61 (6): 523–30. PMID 17348609.
Bossong M, Brunt T, Van Dijk J, et al. (March 2009). „mCPP: an undesired addition to the ecstasy market”. Journal of Psychopharmacology (Oxford, England) 24 (9): 1395–401. DOI:10.1177/0269881109102541. PMID 19304863. ^{[mrtav link]}
Vogels N, Brunt TM, Rigter S, van Dijk P, Vervaeke H, Niesink RJ (December 2009). „Content of ecstasy in the Netherlands: 1993-2008”. Addiction (Abingdon, England) 104 (12): 2057–66. DOI:10.1111/j.1360-0443.2009.02707.x. PMID 19804461. Arhivirano iz originala na datum 2013-01-05. Pristupljeno 2014-04-05.
Tancer M, Johanson CE (October 2003). „Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP”. Drug and Alcohol Dependence 72 (1): 33–44. DOI:10.1016/S0376-8716(03)00172-8. PMID 14563541.
Rajkumar R, Pandey DK, Mahesh R, Radha R (April 2009). „1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay”. European Journal of Pharmacology 608 (1-3): 32–41. DOI:10.1016/j.ejphar.2009.02.041. PMID 19269287.
Kennett GA, Whitton P, Shah K, Curzon G (May 1989). „Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists”. European Journal of Pharmacology 164 (3): 445–54. DOI:10.1016/0014-2999(89)90252-5. PMID 2767117.
Klein E, Zohar J, Geraci MF, Murphy DL, Uhde TW (November 1991). „Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects”. Biological Psychiatry 30 (10): 973–84. DOI:10.1016/0006-3223(91)90119-7. PMID 1756202.
Charney DS, Woods SW, Goodman WK, Heninger GR (1987). „Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects”. Psychopharmacology 92 (1): 14–24. PMID 3110824.
Van Veen JF, Van der Wee NJ, Fiselier J, Van Vliet IM, Westenberg HG (October 2007). „Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine (m-CPP) in patients with generalized social anxiety disorder, panic disorder and healthy controls”. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology 17 (10): 637–42. DOI:10.1016/j.euroneuro.2007.03.005. PMID 17481859.
van der Wee NJ, Fiselier J, van Megen HJ, Westenberg HG (October 2004). „Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine in patients with panic disorder and controls”. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology 14 (5): 413–7. DOI:10.1016/j.euroneuro.2004.01.001. PMID 15336303.
Hollander E, DeCaria CM, Nitescu A, et al. (January 1992). „Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers”. Archives of General Psychiatry 49 (1): 21–8. PMID 1728249. ^{[mrtav link]}
Broocks A, Pigott TA, Hill JL, et al. (June 1998). „Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive-compulsive disorder (OCD): behavioral and biological results”. Psychiatry Research 79 (1): 11–20. DOI:10.1016/S0165-1781(98)00029-8. PMID 9676822.
Pigott TA, Zohar J, Hill JL, et al. (March 1991). „Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder”. Biological Psychiatry 29 (5): 418–26. DOI:10.1016/0006-3223(91)90264-M. PMID 2018816.

sagepub.com

jop.sagepub.com

Bossong M, Brunt T, Van Dijk J, et al. (March 2009). „mCPP: an undesired addition to the ecstasy market”. Journal of Psychopharmacology (Oxford, England) 24 (9): 1395–401. DOI:10.1177/0269881109102541. PMID 19304863. ^{[mrtav link]}

sciencedirect.com

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

wikipedia.org

sh.wikipedia.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

wiley.com

www3.interscience.wiley.com

Bossong MG, Van Dijk JP, Niesink RJ (December 2005). „Methylone and mCPP, two new drugs of abuse?”. Addiction Biology 10 (4): 321–3. DOI:10.1080/13556210500350794. PMID 16318952. Arhivirano iz originala na datum 2013-01-05. Pristupljeno 2014-04-05.
Vogels N, Brunt TM, Rigter S, van Dijk P, Vervaeke H, Niesink RJ (December 2009). „Content of ecstasy in the Netherlands: 1993-2008”. Addiction (Abingdon, England) 104 (12): 2057–66. DOI:10.1111/j.1360-0443.2009.02707.x. PMID 19804461. Arhivirano iz originala na datum 2013-01-05. Pristupljeno 2014-04-05.